Dynamic Contrast-Enhanced MR Imaging in a Phase Ⅱ Study on Neoadjuvant Chemotherapy Combining Rh-Endostatin with Docetaxel and Epirubicin for Locally Advanced Breast Cancer

Background: Anti-angiogenesis is a promising therapeutic strategy for locally advanced breast cancer. We performed this phase II trial to evaluate the anti-angiogenesis and anti-tumor effect of rh-endostatin combined with docetaxel and epirubicin in patients with locally advanced breast cancer by dy...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Qianxin, Xu, Junqing, Jiang, Weifeng, Zheng, Minwen, Wei, Mengqi, Chen, Jianghao, Wang, Ling, Huan, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547207/
https://www.ncbi.nlm.nih.gov/pubmed/23329881
http://dx.doi.org/10.7150/ijms.5123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547207/
https://www.ncbi.nlm.nih.gov/pubmed/23329881
http://dx.doi.org/10.7150/ijms.5123

Ejemplares similares